X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7528) 7528
Book Review (1166) 1166
Newsletter (669) 669
Newspaper Article (365) 365
Publication (342) 342
Magazine Article (148) 148
Transcript (54) 54
Conference Proceeding (22) 22
Trade Publication Article (15) 15
Book Chapter (12) 12
Dissertation (6) 6
Book / eBook (5) 5
Government Document (3) 3
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6504) 6504
humans (5306) 5306
male (4106) 4106
anticholesteremic agents (2946) 2946
female (2941) 2941
anticholesteremic agents - therapeutic use (2804) 2804
cholesterol (2588) 2588
anticholesteremic agents - administration & dosage (2509) 2509
animals (2322) 2322
middle aged (2321) 2321
anticholesteremic agents - pharmacology (1866) 1866
aged (1643) 1643
hypercholesterolemia - drug therapy (1565) 1565
cholesterol, ldl - blood (1542) 1542
adult (1498) 1498
cholesterol - blood (1461) 1461
hypercholesterolemia (1334) 1334
pharmacology & pharmacy (1274) 1274
statins (1199) 1199
rats (1139) 1139
abridged index medicus (1079) 1079
risk factors (1030) 1030
cardiac & cardiovascular systems (1018) 1018
anticholesteremic agents - adverse effects (1003) 1003
treatment outcome (1002) 1002
atherosclerosis (996) 996
simvastatin (964) 964
low density lipoproteins (900) 900
lipids (868) 868
atorvastatin calcium (864) 864
drug therapy, combination (863) 863
research (823) 823
triglycerides - blood (822) 822
ezetimibe (810) 810
drug therapy (806) 806
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (763) 763
hypercholesterolemia - blood (730) 730
medicine, general & internal (699) 699
atorvastatin (684) 684
dose-response relationship, drug (659) 659
cholesterol, hdl - blood (651) 651
analysis (649) 649
mice (638) 638
double-blind method (622) 622
prevention (620) 620
cardiovascular disease (619) 619
dosage and administration (605) 605
lipids - blood (605) 605
coronary-heart-disease (601) 601
care and treatment (578) 578
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (555) 555
pravastatin (551) 551
health aspects (529) 529
peripheral vascular disease (521) 521
heptanoic acids - administration & dosage (517) 517
pyrroles - administration & dosage (510) 510
cholesterol - metabolism (501) 501
time factors (500) 500
diet (484) 484
cardiovascular diseases - prevention & control (477) 477
physiological aspects (477) 477
metabolism (472) 472
risk (470) 470
liver - metabolism (469) 469
simvastatin - administration & dosage (461) 461
cardiovascular agents (460) 460
nutrition & dietetics (460) 460
biochemistry & molecular biology (445) 445
pharmaceutical industry (443) 443
heptanoic acids - therapeutic use (441) 441
hyperlipidemias - drug therapy (428) 428
pyrroles - therapeutic use (428) 428
liver - drug effects (425) 425
cardiovascular-disease (401) 401
lipoproteins (401) 401
therapy (394) 394
diabetes (393) 393
disease (391) 391
coronary heart disease (387) 387
clinical trials (379) 379
safety (376) 376
cardiovascular (371) 371
triglycerides (369) 369
efficacy (367) 367
simvastatin - therapeutic use (364) 364
density-lipoprotein cholesterol (362) 362
antilipemic agents (357) 357
cardiovascular diseases (356) 356
azetidines - administration & dosage (352) 352
anticholesteremic agents - pharmacokinetics (347) 347
medical research (347) 347
cardiology (346) 346
azetidines - therapeutic use (344) 344
endocrinology & metabolism (344) 344
low-density-lipoprotein (339) 339
liver (334) 334
hyperlipidemia (329) 329
medicine & public health (324) 324
blood cholesterol (321) 321
rats, sprague-dawley (318) 318
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8232) 8232
German (137) 137
Russian (72) 72
Swedish (58) 58
Spanish (42) 42
Norwegian (41) 41
French (39) 39
Danish (32) 32
Italian (25) 25
Japanese (25) 25
Polish (19) 19
Chinese (17) 17
Hungarian (15) 15
Czech (10) 10
Dutch (8) 8
Hebrew (2) 2
Lithuanian (2) 2
Portuguese (2) 2
Croatian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 1/2008, Volume 100, Issue 2, pp. 134 - 139
Journal Article
International Journal of Clinical Practice, ISSN 1368-5031, 08/2010, Volume 64, Issue 9, pp. 1220 - 1227
Aim:  Our objective was to investigate the effects and tolerability of fixed‐dose combination therapy on blood pressure and LDL in adults without elevated... 
STROKE | WOMEN | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | CHOLESTEROL | ISCHEMIC-HEART-DISEASE | ESOPHAGEAL CANCER | ASPIRIN | BLOOD-PRESSURE | PRIMARY PREVENTION | Antihypertensive Agents - pharmacology | Tablets | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Aspirin - administration & dosage | Hydrochlorothiazide - pharmacology | Pyrroles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Heptanoic Acids - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Female | Blood Pressure - drug effects | Aspirin - pharmacology | Enalapril - administration & dosage | Heptanoic Acids - pharmacology | Cardiovascular Diseases - etiology | Double-Blind Method | Risk Factors | Cholesterol, LDL - drug effects | Hydrochlorothiazide - administration & dosage | Atorvastatin Calcium | Pilot Projects | Pyrroles - pharmacology | Enalapril - pharmacology | Anticholesteremic Agents - administration & dosage | Aged | Chronic Disease | Anticholesteremic Agents - pharmacology | Drug Combinations | Hypertension | Aspirin | Blood cholesterol | Gastrointestinal diseases | Low density lipoproteins | Pharmacy | Clinical trials | Drug therapy, Combination | Universities and colleges | Risk factors | Public health | Disease prevention | Pharmacology | Blood pressure | Low density lipoprotein | Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2018, Volume 20, Issue 6, pp. 1479 - 1489
Aim: To compare alirocumab, a proprotein convertase subtilisin-kexin type 9 inhibitor, with usual care (UC) in individuals with type 2 diabetes (T2DM) and... 
type 2 diabetes | mixed dyslipidaemia | non‐HDL cholesterol | PCSK | PCSK9 | non-HDL cholesterol | METAANALYSIS | EFFICACY | CARDIOVASCULAR EVENTS | SAFETY | RISK | PCSK9 INHIBITOR EVOLOCUMAB | GENETIC-VARIANTS | DENSITY-LIPOPROTEIN CHOLESTEROL | ENDOCRINOLOGY & METABOLISM | POOLED ANALYSIS | AMG 145 | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Dyslipidemias - drug therapy | Double-Blind Method | Drug Administration Schedule | Cholesterol, HDL - metabolism | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Treatment Outcome | Proprotein Convertase 9 - metabolism | Anticholesteremic Agents - adverse effects | Diabetes Mellitus, Type 2 - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hypoglycemic Agents - administration & dosage | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Lipid Metabolism - drug effects | Female | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Blood cholesterol | Analysis | Low density lipoproteins | Glycosylated hemoglobin | Apolipoproteins | Niacin | Trans fatty acids | Statins | Diabetes therapy | Lipoproteins (low density) | Diabetes mellitus | Dyslipidemia | Nicotinic acid | Subtilisin | Low density lipoprotein | Cholesterol | Apolipoprotein B | Fenofibrate | Kexin | Motivation | Hemoglobin | Diabetes | Diabetes mellitus (non-insulin dependent) | Lipoproteins (high density) | Index Medicus | Original
Journal Article
European Heart Journal, ISSN 0195-668X, 09/2014, Volume 35, Issue 33, pp. 2249 - 2259
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2011, Volume 103, Issue 11, pp. 885 - 892
Journal Article
Journal of Ethnopharmacology, ISSN 0378-8741, 10/2011, Volume 138, Issue 1, pp. 111 - 118
: Berberine is an isoquinoline alkaloid isolated from the root and bark of plants such as goldenseal, , and Chinese goldthread. Berberine-containing crude... 
Berberine | Liver | Drug–drug interactions | Drug-drug interactions | CHEMISTRY, MEDICINAL | RATS | GOLDENSEAL | MOUSE-LIVER | INDUCTION | PLANT SCIENCES | INHIBITION | KAVA-KAVA | PPAR | METABOLISM | INTEGRATIVE & COMPLEMENTARY MEDICINE | INSULIN-RESISTANCE | IN-VIVO | PHARMACOLOGY & PHARMACY | Antihypertensive Agents - pharmacology | Berberine - administration & dosage | Gene Expression - drug effects | Plant Extracts - pharmacology | Antihypertensive Agents - administration & dosage | Cytochrome P-450 Enzyme System - metabolism | Male | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Plant Extracts - administration & dosage | Hypoglycemic Agents - administration & dosage | Liver - drug effects | Plants, Medicinal - chemistry | Administration, Oral | Mice, Inbred C57BL | Anticholesteremic Agents - adverse effects | Antihypertensive Agents - adverse effects | Hypoglycemic Agents - pharmacology | Berberine - pharmacology | Animals | Anticholesteremic Agents - administration & dosage | Herb-Drug Interactions | Cytochrome P-450 Enzyme System - genetics | Mice | Berberine - adverse effects | Hypoglycemic Agents - adverse effects | Anticholesteremic Agents - pharmacology | Plant Extracts - adverse effects | Phosphates | Pharmacogenetics | Messenger RNA | Drug interactions | Cytochrome P-450 | Mass spectrometry | Sugars | Monosaccharides | Drugs | Hypertension | Enzymes | Cytochrome P450 | Diabetes mellitus | Roots | Bark | Oral administration | Antimicrobial agents | CYP1A2 protein | Gene expression | Nuclear receptors | Risk factors | Infection | Alkaloids | Hypercholesterolemia | Index Medicus | liver | drug-drug interactions
Journal Article
Journal of Ethnopharmacology, ISSN 0378-8741, 02/2017, Volume 198, pp. 399 - 406
Baker (Asteraceae) is traditionally used in South American Countries as an anti-inflammatory, analgesic and hepatoprotective. This study aimed to investigate... 
Vernonia condensate | Hepatoprotective | Antioxidant | 1,5-dicaffeoylquinic acid | Anti-inflammatory | CHEMISTRY, MEDICINAL | RAW 264.7 | FLAVONOIDS | ACUTE TOXICITY | PLANT SCIENCES | NITRIC-OXIDE PRODUCTION | ACETAMINOPHEN | TETRACHLORIDE-INDUCED HEPATOTOXICITY | CHLOROGENIC ACID | INTEGRATIVE & COMPLEMENTARY MEDICINE | KUPFFER CELLS | PHARMACOLOGY & PHARMACY | TNF-ALPHA | EXTRACT | Rats, Wistar | Drug Overdose | Plant Extracts - pharmacology | Plant Leaves | Acetaminophen - administration & dosage | Male | Dose-Response Relationship, Drug | Plant Extracts - administration & dosage | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - isolation & purification | Silymarin - pharmacology | Vernonia - chemistry | Chemical and Drug Induced Liver Injury - etiology | Cell Line | Chemical and Drug Induced Liver Injury - prevention & control | Cytokines - metabolism | Acetaminophen - toxicity | Anti-Inflammatory Agents - pharmacology | Rats | Antioxidants - pharmacology | Anticholesteremic Agents - isolation & purification | Macrophages - metabolism | Animals | Antioxidants - isolation & purification | Anticholesteremic Agents - administration & dosage | Antioxidants - administration & dosage | Macrophages - drug effects | Mice | Anticholesteremic Agents - pharmacology | Antioxidants | Research institutes | Anti-inflammatory drugs | Analysis | Anticholesteremic agents | Medicinal plants | Analysis and chemistry | Low density lipoproteins | Medicine, Botanic | Esters | Medicine, Herbal | Blood | Index Medicus
Journal Article
Journal Article
Journal Article
Atherosclerosis, ISSN 0021-9150, 2015, Volume 244, pp. 138 - 146
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 8/2007, Volume 166, Issue 3, pp. 348 - 354
Journal Article